In This Section      
 

Promise and Progress - New Appointments & New Faculty

Promise & Progress - A Spectrum of Achievements

New Appointments & New Faculty

Date: January 15, 2015


Satish Shanbhag, M.B.B.S., M.P.H., is the new medical director of Johns Hopkins Bayview Medical Center’s oncology/hematology outpatient practice. His leadership will include collaborations with leaders in upper aerodigestive diseases, radiation oncology, pulmonary medicine, and thoracic surgery to foster a patient-centered, safe, efficient and evidence-based environment.

has been appointed assistant director for faculty affairs. She will chair the department of oncology’s Appointments, Promotions, and Career Development Committee, which oversees the selection of individuals for appointment to the faculty and for promotion.  The committee also oversees mentoring programs to ensure the success of our junior faculty.

 

New Faculty

Lukasz Gondek, M.D., Ph.D., instructor in oncology, joined the hematologic malignancies program. Gondek is a physician-scientist with a strong background in both basic-translational research and medicine, with a particular interest in the biology of myelodysplasia.  He has pioneered many of the seminal findings in the field of myelosdysplastic syndrome (MDS) and leukemia genetics. He plans to develop a laboratory-based translational research program focused on MDS stem cell biology and targeted therapies in myelodysplasia and will work closely with members of the adult clinical leukemia service to translate his findings to the clinic. Gondek earned his medical degree at the Medical University of Silesia in Katowice, Poland and completed his doctorate and residency at the Cleveland Clinic before coming came to the Kimmel Cancer Center for a hematology/oncology fellowship in William Matsui’s laboratory.

Jeffrey S. Huo, M.D., Ph.D., has joined the Pediatric Oncology Program as an instructor of oncology and pediatrics.  Huo’s research is focused on the relationship between cancer epigenetic reprogramming in stem cells. He is developing a stem cell model of human retinoblastoma.  Huo is a Maryland Stem Cell Research Fund postdoctoral fellow and Alex’s Lemonade Stand Young Investigator. Huo was a magna cum laude graduate of Northwestern University’s honors program in medical education. He received his medical degree and doctorate in cellular and molecular biology through the University of Michigan’s medical scientist training program.  He completed his residency in pediatrics at Washington University School of Medicine in St. Louise and completed a combined pediatric hematology/oncology fellowship through the Johns Hopkins/National Cancer Institute joint program.

Nicolas J. Llosa, M.D., instructor of pediatrics and oncology, is a new member of the Pediatric Oncology Program. His research focuses on understanding immune checkpoint expression in the tumor microenvironment in sarcomas and other cancers, and using his findings to identify potential biomarkers for immunotherapeutic interventions that involve checkpoint blockade. Llosa received his medical degree from the National University of Cuyo in Argentina and completed a fellowship in medical research at the Brigham and Women’s Hospital in Boston. He was chief pediatrics resident at Tufts. He served as chief fellow in the Johns Hopkins/National Cancer Institute joint pediatric hematology and oncology fellowship program.

Allison Martin, M.D., has joined the Pediatric Oncology Program as an instructor in pediatrics and oncology. She is researching immune therapy strategies, including the immune blockade target PD-L1, in pediatric brain tumors with the aim of developing a phase I clinical trial of anti-PD-1 therapy in pediatric brain tumors. Martin received her medical degree from Jefferson Medical College.  She completed her pediatric residency at Children’s Hospital of Pittsburgh before joining the Johns Hopkins/National Cancer Institute pediatric hematology and oncology joint fellowship program followed by a yearlong specialized training in pediatric neuro-oncology. 

Christine Pratilas, M.D., assistant professor of oncology and pediatrics, was selected after an international search to join the Pediatric Oncology Program.  Pratilas will specialize in pediatric sarcomas and other solid tumors.  She comes to the Kimmel Cancer Center from Memorial Sloan Kettering Cancer Center where she was a faculty member for eight years.  She conducted research on signal transduction pathways with the aim of developing new targeted cancer therapies, and she will continue this work here with a specific focus on novel therapeutics for patients with sarcoma.

Ravi Varadhan, Ph.D., has joined the Biostatistics and Bioinformatics Division as an associate professor of oncology in the Division of Biostatistics and Bioinformatics. He also holds joint appointments at the Johns Hopkins Center on Aging and Health and Department of Biostatistics and at the Bloomberg School of Public Health Center for Drug Safety and Effectiveness.Ravi is a highly-trained mathematical modeler with doctorates in environmental engineering and biostatistics. He is a co-director for the Biostatistics and Epidemiology of Aging Training Program at Johns Hopkins and has published numerous articles in engineering, environmental science, applied mathematics, statistics, epidemiology, gerontology, and biomedical journals. As part of the Kimmel Cancer Center team, he will be collaborating with the clinical researchers and will provide biostatistics expertise for the design and analysis of clinical trials, retrospective studies, and laboratory studies.

Find Physicians Specializing In...